These Are the Only 3 Stocks That Cathie Wood Bought Last Week [Yahoo! Finance]
Arcturus Therapeutics Holdings Inc. (ARCT)
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arcturusrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Growing investing icon Cathie Wood -- the founder, CEO, and primary stock picker of Ark Invest's family of ETFs -- has historically used pullbacks to load up on falling favorites, but she was surprisingly quiet this time. Ark Invest added to only three existing positions last week. She bought shares in Figma (NYSE: FIG) Arcturus Therapeutics Holdings (NASDAQ: ARCT) , and 10x Genomics (NASDAQ: TXG) . Having a light hand as many of her stocks corrected is unusual for Wood, but it should also find investors hungry to understand why she chose these three names. Let's take a closer look at Wood's latest Ark Invest purchases. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. 1. Figma One of the hottest IPOs out of the gate last year has cooled down in a major way. Figma, a provider of w
Show less
Read more
Impact Snapshot
Event Time:
ARCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCT alerts
High impacting Arcturus Therapeutics Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ARCT
News
- Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf [Yahoo! Finance]Yahoo! Finance
- Arcturus Therapeutics (ARCT) was upgraded by B. Riley Financial, Inc. to "strong-buy".MarketBeat
- Arcturus Therapeutics (ARCT) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $22.00 price target on the stock.MarketBeat
- Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing [Yahoo! Finance]Yahoo! Finance
- Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus [Seeking Alpha]Seeking Alpha
ARCT
Earnings
- 3/3/26 - Miss
ARCT
Sec Filings
- 3/3/26 - Form 10-K
- 3/3/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- ARCT's page on the SEC website